Medicure Inc. (CVE:MPH – Get Free Report)’s share price hit a new 52-week low on Thursday . The company traded as low as C$0.67 and last traded at C$0.67, with a volume of 16000 shares. The stock had previously closed at C$0.81.
Medicure Trading Down 14.3 %
The company has a current ratio of 2.03, a quick ratio of 1.29 and a debt-to-equity ratio of 4.65. The company’s fifty day moving average is C$0.84 and its 200-day moving average is C$0.92. The firm has a market capitalization of C$7.20 million, a P/E ratio of -3.54 and a beta of 0.90.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Featured Stories
- Five stocks we like better than Medicure
- What is Forex and How Does it Work?
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- 3 Dividend Kings To Consider
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- 3 Monster Growth Stocks to Buy Now
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
